Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Inhibitors-Cancer'

Inhibitors-Cancer published presentations and documents on DocSlides.

CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data
CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data
by min-jolicoeur
CDK 4/6 Inhibitors in Breast Cance...
P-glycoprotein inhibitors:
P-glycoprotein inhibitors:
by barbara
“old” chemosensitizers, “new” immune-sensi...
Aromatase Inhibitors
Aromatase Inhibitors
by lucy
Medication Teaching The Center for Breast Cancer ...
Differentiating Among the CDK 4/6 Inhibitors in the Management of Metastatic Breast Cancer
Differentiating Among the CDK 4/6 Inhibitors in the Management of Metastatic Breast Cancer
by min-jolicoeur
This program will include a discussion of off-lab...
Oestrogen attaches to receptors in breast cancer cells enabling the c
Oestrogen attaches to receptors in breast cancer cells enabling the c
by cecilia
tablet the next day.Aromatase inhibitors can inter...
The Use of PARP Inhibitors in Breast Cancer: Challenges
The Use of PARP Inhibitors in Breast Cancer: Challenges
by calandra-battersby
and Opportunities. This program will include a di...
The effect of inhibitors (Inorganic phosphate & Sodium fluoride) on the rate of an enzyme catal
The effect of inhibitors (Inorganic phosphate & Sodium fluoride) on the rate of an enzyme catal
by jainy
322 BCH. Exp. (8). In this experiment, we will co...
Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors
Type 1 Diabetes: Expanding Options for Adjunctive Oral Therapy With SGLT Inhibitors
by yoshiko-marsland
Type 1 Diabetes: Expanding Options for Adjunctive...
CORROSION INHIBITORS
CORROSION INHIBITORS
by min-jolicoeur
Inhibitors. anodic inhibitors. : . p. hosphates...
PDE 5 Inhibitors beyond erectile dysfunction
PDE 5 Inhibitors beyond erectile dysfunction
by marina-yarberry
. ...
The effect of inhibitors (Inorganic phosphate & Sodium
The effect of inhibitors (Inorganic phosphate & Sodium
by alexa-scheidler
322 BCH. Exp. (8). In this experiment, we will c...
Nuclear Transport Inhibitors Alter Capsid Subcellular
Nuclear Transport Inhibitors Alter Capsid Subcellular
by stefany-barnette
Localisation. and Replication of Venezuelan Equi...
Discovery Novel Allosteric Fragment Inhibitors of HIV-1 Rev
Discovery Novel Allosteric Fragment Inhibitors of HIV-1 Rev
by sherrill-nordquist
. A/Prof Gilda Tachedjian. Retroviral Biolo...
The use of immune checkpoint inhibitors to treat many different types of cancers has increased dram
The use of immune checkpoint inhibitors to treat many different types of cancers has increased dram
by joyce
Recognizing an opportunity for improvement in the ...
Osteoclast Inhibitors in Malignancy
Osteoclast Inhibitors in Malignancy
by onionchevrolet
Joel Brothers. 10/4/2016. Understand the indicatio...
Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications
Endocrine Treatment of Metastatic Breast Cancer: New Advances; Patient Education Implications
by calandra-battersby
An Interactive Oncology Grand Rounds Series. Joyc...
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
PARP and Other DNA Damage Repair Inhibitors in Solid Tumors: An Update
by ellena-manuel
Program Overview . Discussion Outline. DNA Repair...
Biomarkers for Cancer Immunotherapy: Understanding Their Growing Role in
Biomarkers for Cancer Immunotherapy: Understanding Their Growing Role in
by yoshiko-marsland
Pan Tumors. This program will include a discussio...
V7: CDK inhibitors http://
V7: CDK inhibitors http://
by okelly
www.nature.com/articles/nrd4504 (2015). https. ://...
CDK4-6 INHIBITORS IN Breast Cancer: Optimal Treatment Sequencing
CDK4-6 INHIBITORS IN Breast Cancer: Optimal Treatment Sequencing
by leah
Mansoor A Khan, BS, MS, BCOP. Oncology/Hematology/...
PARP Inhibitors This program will include a discussion of off-label treatment and investigational a
PARP Inhibitors This program will include a discussion of off-label treatment and investigational a
by conchita-marotz
PARP Inhibitors: What Do We know?. PARP Inhibitor...
PARP Inhibitors and Cancer: What Do You Need to Know?
PARP Inhibitors and Cancer: What Do You Need to Know?
by pasty-toler
This program will include a discussion of off-lab...
Comparative effect of Various HDAC-inhibitors in-vitro on T
Comparative effect of Various HDAC-inhibitors in-vitro on T
by pasty-toler
lines . alone and in combination with convention...
GU CONNECT PARP inhibitors in Prostate Cancer
GU CONNECT PARP inhibitors in Prostate Cancer
by jocelyn
Latest developments. . Prof.. . Neeraj Agarwal, ...
Oncology Basics CANCER TREATMENT MODALITIES
Oncology Basics CANCER TREATMENT MODALITIES
by angelina
Mohammed A. Suwaid, MD. Board-certified Medical On...
Immunotherapy for advanced cervical cancer
Immunotherapy for advanced cervical cancer
by elizabeth
Megan Swanson, MD MPH. Assistant Professor. Gyneco...
Targeting endocrine-resistance pathways in breast cancer
Targeting endocrine-resistance pathways in breast cancer
by alexa-scheidler
Targeting endocrine-resistance pathways in breas...
What’s Positive about Triple Negative Breast Cancer
What’s Positive about Triple Negative Breast Cancer
by myesha-ticknor
What’s Positive about Triple Negative Breast Ca...
Inequalities Access Cancer Types Treatment Variation Cancer Cancer
Inequalities Access Cancer Types Treatment Variation Cancer Cancer
by demetrius348
1. Access and treatment for cancer outline . 2. Ca...
Cancer treatment induced bone loss in breast cancer and prostate cancer: 2023 update
Cancer treatment induced bone loss in breast cancer and prostate cancer: 2023 update
by blanko
Azeez Farooki, MD. Attending Physician, Clinical M...
Cancer Patient organisation involvement in cancer policy and EU cancer Plan priorities
Cancer Patient organisation involvement in cancer policy and EU cancer Plan priorities
by isabella2
Charis Girvalaki. ECPC Director. European Cancer P...
Male breast cancer Meyskens Jr and Janaes Cancer Section Cancer Ins
Male breast cancer Meyskens Jr and Janaes Cancer Section Cancer Ins
by violet
L. MEYSKENS, D. (32, 33), and hormonal (42, 46, (6...
Breast Cancer Cancer : cancer is not just one disease but rather a
Breast Cancer Cancer : cancer is not just one disease but rather a
by SunkissedBabe
group. of diseases. . All forms of cancer cause c...
Pancreatic cancer is the 5th leading cause of death from cancer and the 11th most common cancer in
Pancreatic cancer is the 5th leading cause of death from cancer and the 11th most common cancer in
by WatercolorWanderlust
.. GREEK ORTHODOX LADIES PHILOPTOCHOS SOCIETY, INC...
Community Cancer Clusters Monica Brown, PhD Cancer Epidemiologist, the California Cancer Registry
Community Cancer Clusters Monica Brown, PhD Cancer Epidemiologist, the California Cancer Registry
by jane-oiler
Community Cancer Clusters Monica Brown, PhD Cance...
Lung Cancer Prevention and Early Detection Lung cancer is the second most common cancer in both men and women not counting skin cancer and is by far the leading cause of cancer death among both men an
Lung Cancer Prevention and Early Detection Lung cancer is the second most common cancer in both men and women not counting skin cancer and is by far the leading cause of cancer death among both men an
by luanne-stotts
Each year more people die of lung cancer than of ...
Pancreatic Cancer What is pancreatic cancer? Cancer starts when cells
Pancreatic Cancer What is pancreatic cancer? Cancer starts when cells
by natalia-silvester
What Is Cancer? Pancreatic cancer begins when cell...
Enzyme Inhibition By- Shubhani
Enzyme Inhibition By- Shubhani
by damon448
. singh. thakur. Department of biochemistry. Enzy...
Antihypertensives Hypertension occurs
Antihypertensives Hypertension occurs
by everly
when resting systolic blood pressure exceeds . 130...
Concomitant administration of palbociclib and proton pump inhibitors affects clinical outcomes in m
Concomitant administration of palbociclib and proton pump inhibitors affects clinical outcomes in m
by felicity
Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor...